BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 18991958)

  • 1. Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction.
    Howell LL; Murnane KS
    Ann N Y Acad Sci; 2008 Oct; 1141():176-94. PubMed ID: 18991958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonhuman primate positron emission tomography neuroimaging in drug abuse research.
    Howell LL; Murnane KS
    J Pharmacol Exp Ther; 2011 May; 337(2):324-34. PubMed ID: 21317354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain imaging in nonhuman primates: insights into drug addiction.
    Nader MA; Czoty PW
    ILAR J; 2008; 49(1):89-102. PubMed ID: 18172336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonhuman primate models of addiction and PET imaging: dopamine system dysregulation.
    Gould RW; Porrino LJ; Nader MA
    Curr Top Behav Neurosci; 2012; 11():25-44. PubMed ID: 22020537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroimaging and drug taking in primates.
    Murnane KS; Howell LL
    Psychopharmacology (Berl); 2011 Jul; 216(2):153-71. PubMed ID: 21360099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of Nonhuman Primates in Substance Use Disorders Research.
    Banks ML; Czoty PW; Negus SS
    ILAR J; 2017 Dec; 58(2):202-215. PubMed ID: 28531265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurobiology of addiction: insight from neurochemical imaging.
    Urban NB; Martinez D
    Psychiatr Clin North Am; 2012 Jun; 35(2):521-41. PubMed ID: 22640769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations.
    Gould RW; Duke AN; Nader MA
    Neuropharmacology; 2014 Sep; 84():138-51. PubMed ID: 23458573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional imaging and neurochemical correlates of stimulant self-administration in primates.
    Howell LL; Wilcox KM
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):352-61. PubMed ID: 12373436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation.
    Nader MA; Czoty PW
    Am J Psychiatry; 2005 Aug; 162(8):1473-82. PubMed ID: 16055768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addiction and imaging of the living human brain.
    Gatley SJ; Volkow ND
    Drug Alcohol Depend; 1998; 51(1-2):97-108. PubMed ID: 9716933
    [No Abstract]   [Full Text] [Related]  

  • 12. Addiction.
    Lingford-Hughes AR; Davies SJ; McIver S; Williams TM; Daglish MR; Nutt DJ
    Br Med Bull; 2003; 65():209-22. PubMed ID: 12697627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translating positron emission tomography studies in animals to stimulant addiction: promises and pitfalls.
    Caprioli D; Fryer TD; Sawiak SJ; Aigbirhio FI; Dalley JW
    Curr Opin Neurobiol; 2013 Aug; 23(4):597-606. PubMed ID: 23664005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine addiction: hypothesis derived from imaging studies with PET.
    Volkow ND; Ding YS; Fowler JS; Wang GJ
    J Addict Dis; 1996; 15(4):55-71. PubMed ID: 8943582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography molecular imaging of dopaminergic system in drug addiction.
    Hou H; Tian M; Zhang H
    Anat Rec (Hoboken); 2012 May; 295(5):722-33. PubMed ID: 22467195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain uptake and distribution of the dopamine D3 /D2 receptor partial agonist [11 C]cariprazine: an in vivo positron emission tomography study in nonhuman primates.
    Tóth M; Varrone A; Steiger C; Laszlovszky I; Horváth A; Kiss B; Gyertyán I; Adham N; Halldin C; Gulyás B
    Synapse; 2013 May; 67(5):258-64. PubMed ID: 23238770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental protocols for behavioral imaging: seeing animal models of drug abuse in a new light.
    Aarons AR; Talan A; Schiffer WK
    Curr Top Behav Neurosci; 2012; 11():93-115. PubMed ID: 22411423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical impact of cerebral dopamine-D2 receptor scintigraphy].
    Larisch R; Klimke A
    Nuklearmedizin; 1998; 37(7):245-50. PubMed ID: 9830615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimaging in drug abuse.
    Lindsey KP; Gatley SJ; Volkow ND
    Curr Psychiatry Rep; 2003 Oct; 5(5):355-61. PubMed ID: 13678555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurobiology of substance-related addiction: findings of neuroimaging].
    Kienast T; Wrase J; Heinz A
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S68-76. PubMed ID: 18461548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.